Pierre Fabre Overview

  • Year Founded
  • 1962

Year Founded

  • Status
  • Private

  • Employees
  • 10,000

Employees

Pierre Fabre General Information

Description

Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medical innovation. The company's services are offered through an innovation laboratory that promotes research and development in pharmaceuticals, cosmetics and biotechnological domains so as to develop new drugs and health-friendly products without using chemicals and toxic ingredients, enabling medical researchers to recommend and develop all natural healthcare products abiding by the legal compliance and governmental regulations.

Contact Information

Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 12, Avenue Hoche
  • 75008 Paris
  • France
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 12, Avenue Hoche
  • 75008 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pierre Fabre Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medica
Pharmaceuticals
Paris, France
10,000 As of 2026

Auckland, New Zealand
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pierre Fabre Competitors (18)

One of Pierre Fabre’s 18 competitors is Douglas (Pharmaceuticals and Biotechnology), a Corporation company based in Auckland, New Zealand.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Douglas (Pharmaceuticals and Biotechnology) Corporation Auckland, New Zealand
Novartis Corporation Basel, Switzerland
Evonile Pharma Private Equity-Backed Mumbai, India
Roche Corporation Basel, Switzerland
Lilly USA Corporation Indianapolis, IN
You’re viewing 5 of 18 competitors. Get the full list »

Pierre Fabre Patents

Pierre Fabre Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026087699-A1 New treatment of non-small cell lung cancer Pending 24-Oct-2024
FR-3159741-A1 Topical formulation comprising binimetinib Pending 04-Mar-2024
WO-2025186275-A1 Topical formulation comprising binimetinib Pending 04-Mar-2024
WO-2025186275-A8 Topical formulation comprising binimetinib Pending 04-Mar-2024
FR-3159747-A1 Combination for the treatment of halitosis Pending 29-Feb-2024 A61P1/02
To view Pierre Fabre’s complete patent history, request access »

Pierre Fabre Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pierre Fabre Investments & Acquisitions (17)

Pierre Fabre’s most recent deal was a Corporate Asset Purchase with Antares Therapeutics (Global Assets Of PFL- 721 and PFL-241). The deal was made on 16-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Antares Therapeutics (Global Assets Of PFL- 721 and PFL-241) 16-Jun-2025 Corporate Asset Purchase Buildings and Property
Kinnate Biopharma (Exarafenib And Other Pan-RAF Program Assets) 27-Feb-2024 Corporate Asset Purchase Buildings and Property
TOLREMO therapeutics 20-Sep-2023 Later Stage VC Drug Discovery
Vertical Bio 14-Aug-2023 Merger/Acquisition Biotechnology
Même 12-Apr-2023 Merger/Acquisition Personal Products
You’re viewing 5 of 17 investments and acquisitions. Get the full list »

Pierre Fabre Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Même Paris, France 2015
Pierre Fabre Invest Castres, France 2007
Urogene Paris, France 1998
Ladrôme Laboratoire Saillans, France 1993
Pierre Fabre (United States Rights For Hemangeol)
You’re viewing 5 of 6 affiliates. Get the full list.  »

Pierre Fabre FAQs

  • When was Pierre Fabre founded?

    Pierre Fabre was founded in 1962.

  • Where is Pierre Fabre headquartered?

    Pierre Fabre is headquartered in Paris, France.

  • What is the size of Pierre Fabre?

    Pierre Fabre has 10,000 total employees.

  • What industry is Pierre Fabre in?

    Pierre Fabre’s primary industry is Pharmaceuticals.

  • Is Pierre Fabre a private or public company?

    Pierre Fabre is a Private company.

  • What is Pierre Fabre’s current revenue?

    The current revenue for Pierre Fabre is .

  • Who are Pierre Fabre’s competitors?

    Douglas (Pharmaceuticals and Biotechnology), Novartis, Evonile Pharma, Roche, and Lilly USA are some of the 18 competitors of Pierre Fabre.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process